REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,479,800 | +3.5% | 53,461 | 0.0% | 0.01% | +9.1% |
| Q2 2023 | $1,430,082 | +44.9% | 53,461 | +17.3% | 0.01% | +57.1% |
| Q1 2023 | $987,176 | +4.9% | 45,576 | +15.3% | 0.01% | 0.0% |
| Q4 2022 | $941,295 | +20.8% | 39,517 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $779,275 | +16.7% | 39,517 | +15.4% | 0.01% | +40.0% |
| Q2 2022 | $667,649 | -23.6% | 34,256 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $873,871 | +60.6% | 34,256 | +58.5% | 0.01% | +20.0% |
| Q4 2021 | $543,999 | -8.5% | 21,613 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $594,574 | -13.3% | 21,613 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $685,997 | -10.2% | 21,613 | +29.8% | 0.01% | 0.0% |
| Q1 2021 | $764,223 | +15.9% | 16,657 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $659,451 | +13.8% | 16,657 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $579,664 | +161.9% | 16,657 | +137.5% | 0.01% | +100.0% |
| Q2 2020 | $221,369 | +44.1% | 7,012 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $153,633 | – | 7,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |